Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion type Assertion NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_head.
- NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion description "[Highly active antiretroviral therapy with HIV RNA levels less than 400 copies/mL was associated with protection (IRR, 0.2 [CI, 0.1 to 0.5]), but HAART in those with HIV RNA levels of 400 copies/mL or greater was not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_provenance.
- NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion evidence source_evidence_literature NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_provenance.
- NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion SIO_000772 26457744 NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_provenance.
- NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion wasDerivedFrom befree-2016 NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_provenance.
- NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_assertion wasGeneratedBy ECO_0000203 NP1294845.RAA8ilxfXGwYwI-INh-z0SZWSusRdPTyH5pwGh1SLRykg130_provenance.